Nina Lauterbach1, Lotte Wieten1, Herman E Popeijus2, Christina E M Voorter1, Marcel G J Tilanus3. 1. Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands. 2. NUTRIM School for Nutrition, Toxicology and Metabolism, Department of Human Biology, Maastricht University, Maastricht, The Netherlands. 3. Transplantation Immunology, Tissue Typing Laboratory, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address: m.tilanus@mumc.nl.
Abstract
UNLABELLED: NK cells interact with the HLA-E molecule via the inhibitory receptor NKG2A and the activating receptor NKG2C. Hence, HLA-E can have a dual role in the immune response. In the present study, we aim to investigate the functional consequences of HLA-E for NKG2A and NKG2C expressing NK cell subsets by using a panel of HLA-E binding peptides derived from CMV, Hsp60 and HLA class I. PBMC derived from healthy subjects were used as targets for isolated NK cells and NK cell activation was examined by analysis of the expression of the degranulation marker CD107a. Peptide induced HLA-E expression inhibited degranulation of NKG2A+ NK cell subsets with almost all peptides, whereas NKG2A- NKG2C+ NK cell responses were enhanced only after incubation with four peptides; 1.3-fold with CMV(I), A80 and B13 and 3.2-fold with HLA-G derived peptide. In addition, the HLA-E:G peptide complex triggered NKG2C receptor internalization, as evidenced by reduction in the percentage of NKG2C+ NK cells when incubated with the peptide, which could be restored by addition of Bafilomycin. IN CONCLUSION: in contrast to NKG2A, NKG2C is regulated by HLA-E only when HLA-E is in complex with a restricted peptide repertoire, especially in combination with the HLA-G leader peptide.
UNLABELLED: NK cells interact with the HLA-E molecule via the inhibitory receptor NKG2A and the activating receptor NKG2C. Hence, HLA-E can have a dual role in the immune response. In the present study, we aim to investigate the functional consequences of HLA-E for NKG2A and NKG2C expressing NK cell subsets by using a panel of HLA-E binding peptides derived from CMV, Hsp60 and HLA class I. PBMC derived from healthy subjects were used as targets for isolated NK cells and NK cell activation was examined by analysis of the expression of the degranulation marker CD107a. Peptide induced HLA-E expression inhibited degranulation of NKG2A+ NK cell subsets with almost all peptides, whereas NKG2A- NKG2C+ NK cell responses were enhanced only after incubation with four peptides; 1.3-fold with CMV(I), A80 and B13 and 3.2-fold with HLA-G derived peptide. In addition, the HLA-E:G peptide complex triggered NKG2C receptor internalization, as evidenced by reduction in the percentage of NKG2C+ NK cells when incubated with the peptide, which could be restored by addition of Bafilomycin. IN CONCLUSION: in contrast to NKG2A, NKG2C is regulated by HLA-E only when HLA-E is in complex with a restricted peptide repertoire, especially in combination with the HLA-G leader peptide.
Authors: Aimee Merino; Bin Zhang; Philip Dougherty; Xianghua Luo; Jinhua Wang; Bruce R Blazar; Jeffrey S Miller; Frank Cichocki Journal: J Clin Invest Date: 2019-06-18 Impact factor: 14.808
Authors: Tomas Hrbac; Alena Kopkova; Frantisek Siegl; Marek Vecera; Michaela Ruckova; Tomas Kazda; Radim Jancalek; Michal Hendrych; Marketa Hermanova; Vaclav Vybihal; Pavel Fadrus; Martin Smrcka; Filip Sokol; Vaclav Kubes; Radim Lipina; Ondrej Slaby; Leos Kren; Jiri Sana Journal: Cancer Genomics Proteomics Date: 2022 Mar-Apr Impact factor: 4.069
Authors: Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten Journal: Front Immunol Date: 2021-07-06 Impact factor: 7.561
Authors: Emily Chiu; Martin Felices; Frank Cichocki; Zachary Davis; Hongbo Wang; Katie Tuninga; Daniel A Vallera; Tom Lee; Ryan Bjordahl; Karl Johan Malmberg; Bahram Valamehr; Jeffrey S Miller Journal: Mol Ther Date: 2021-06-24 Impact factor: 11.454